PROFOUND changes in the endocrinology of the host result from the growth of not only the so-called functional endocrine tumours but also from the progressive growth of non-functional tumours. Begg and Stewart (1952) and Begg (1955) Nelson and Steinberger (1952) following the administration of furadroxyl, a drug having a similar actioli to that of nitrofurazone. The present work deals with some effects of i-iitrofurazone in normal and tumour-bearing rats. Should nitrofurazone be shown to have an androgenic action in the rat as it does in the mouse, it would then be possible to employ the drug as a stimulus to endogenous pituitary gonadotrophin secretion in tumour-bearing rats and prevent progressive atrophy of the accessory sex organs.
.
. the presence of a tumour produces a deficiency of gonadotrophic hormone in the rat ". These observations have been confirmed and extended by Haddow, Horning and Carlton Smith (1957) , who found that testicular changes were not as consistent as those reported previously and were restricted to an increase in number and lipid content of the Sertoli cells. Marked hypertrophy of the adrenals was a consistent finding, and in some cases was associated with hypertrophic changes in the pituitary gland. Atrophy of the accessory sex organs could be reversed by testosterone propionate, serum gonadotrophii-i or by the subcutaneous implantation of pituitary glands. Nissim (1957) found that nitrofurazone, an anti-bacterial drug sometimes used in infections of the urinary tract, when added to the diet of mice in concentrations of 0-15-0-3 per cent resulted in atrophy of the spermatogeiiic epithelium of the testes, interstitial cell hyperplasia, and hypertrophy of the seminal vesicle. The effect was absent in hypophysectomized mice, and he suggested that the androgenic action may be a manifestation of hyperactivity of the pituitary due to the release from a pituitary inhibiting factor normally liberated from the germ cells of the testes. Castration cells in the pituitary-an indication of hyperactivity of gonadotrophic basophils-have been reported by Nelson and Steinberger (1952) Treatment with 10 mg. of nitrofurazone daily for 10 days had no effect on body weight nor on the weight of the tumour at necropsy when compared with the untreated tumour-bearers. Nor were the testes of the treated group of rats different from those of the untreated tumour-bearers in gross weight and in histological appearance. In fact, the only notable effect of this treatment was the almost complete restoration of the weight and histological appearance of the seminal vesicle to that seen in normal male rats of the same age (Fig. 3b) (Begg, 1955) , testosterone propionate, or by the implantation of fresh pituitary glands (Haddow et al., 1957) . The results of the present study show that a protective action against these changes is provided by the daily administration of nitrofurazone (Table INT and Fig. 3b) .
The androgenic action of nitrofurazone shown by Nissim (1957) to be present in the mouse may also be obtained in the rat. Both species respond to treatment with profound degenerative changes in the spermatogenic epithelium of the seminiferous tubules, but hypertrophy of the accessory sex organs is less dramatic than that described in the mouse. The reason for this difference may be that degeneration of the spermatogenic epithelium in the rat testes was not accompanied by any noticeable hyperplasia of the interstitial tissue. Hyperplasia of Leydigcell tissue was more apparent than real, due to the large interstitial spaces left by the shrunken and distorted atrophic tubules (Fig. la) . Further, mitotic figures were not more numerous in the interstitial tissue of nitrofurazone-treated rats than in that of untreated normal rats.
The results of these experiments allow some comment on the possible mechanism of the androgenic action of nitrofurazone. Nissim (1957) suggested that this action is attributable to increased pituitary gonadotrophin activity consequent on the withdrawal of an " inhibitory substance " normally liberated by the intact seminiferous tubules. In the experiments on the rat reported here, the maximum hypertrophy of the seminal vesicle-or, more accurately, the greatest inhibition of seminal vesicle atrophy-was seen in those rats that did not show degenerative changes in the spermatogenic epithelium (Table IV) . This would indicate that the postulated increase in pituitary gonadotrophin activity following treatment with nitrofurazone is not necessarily dependent on initial degeneration of the spermatogenic epithelium of the testes.
An adequate explanation for the failure of nitrofurazone feeding to prevent atrophy of the accessory sex organs of the rats shown in Table III is wanting However, since administration of the drug by the intraperitoneal route did not produce anorexia and weight loss, the severe under-nutrition associated with the feeding experiments may have resulted in a pituitary gland refractory to any stimulatory action of the drug. Mulinos and Pomerantz (1940) have compared the hormonal imbalances of malnutrition to that of surgical hypophvsectomy and described this pheiiomenon as a dietary pseudo-hypophysectomy.
Some degree of nutritional deficiency or metabolic alteration probably plays a niajor role on the atrophic changes seen in the accessory sex organs and to a lesser extent in the gonads associated with the progressive growth of a tumour. Hormotial imbalances may be effected by retention of gonadotrophic hormone by the pituitary basophils in a similar manner to that described by Rinaldini (1949) and Pearse and Rinaldini (1950) 3. Atrophic changes in the seminal vesicle consisting of a reduction in height of the secretory epithelial cells, a reduction in the amount of seminal secretion, and a notable increase in fibro-muscular stroma of the gland were associated with growth of the Walker tumour. The degree of atrophy was significantly correlated with the weight of the tumour.
4. Addition of nitrofurazone to the diet of tumour-bearing rats failed to prevent atrophy of the seminal vesicle and prostate glands. Degeneration of the spermatogenic epithelium of the testes was similar to that seen in normal rats.
5. Intraperitoneal administration of 10 mg. of nitrofurazone for 10 days protected tumour-bearing rats against atrophy of the accessory sex organs. This protection was associated with no abnormal change in body weight, nor in weight or histological appearance of the testes.
6. These findings are compared with the previously reported effects of nitrofurazone in the mouse. It is suggested that cytological studies of the pituitary gland of tumour-bearing rats would provide a clearer understanding of the hormonal imbalances associated with the growth of tumours. Vol. X.IV,, No. 
